Back to Search Start Over

DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells.

Authors :
Camponeschi A
Todi L
Cristofoletti C
Lazzeri C
Carbonari M
Mitrevski M
Marrapodi R
Del Padre M
Fiorilli M
Casato M
Visentini M
Source :
Immunology letters [Immunol Lett] 2018 Jun; Vol. 198, pp. 7-11. Date of Electronic Publication: 2018 Mar 29.
Publication Year :
2018

Abstract

The transcription factor DEC1/STRA13 (also known as BHLHE40 and SHARP2) is involved in a number of processes including inhibition of cell proliferation and delay of cell cycle, and is a negative regulator of B cell activation and development in mice. We show here that, unlike in mice, DEC1/STRA13 expression is induced in human naïve and memory resting B cells by activation through the B-cell receptor (BCR) or Toll-like receptor 9 (TLR9). siRNA silencing of DEC1/STRA13 increases the capacity of activated B cells to perform a high number of divisions after TLR9 ligation. This identifies DEC1/STRA13 as a critical negative regulator of clonal expansion of activated human B cells. We also show that DEC1/STRA13 is upregulated in human anergic CD21 <superscript>low</superscript> B cells clonally expanded in patients with HCV-associated mixed cryoglobulinemia, which fail to proliferate in response to BCR or TLR9 ligation. siRNA knockdown of DEC1/STRA13, however, fails to restore responsiveness to stimuli in these cells, although it might improve the proliferative capacity in a subset of anergic cells with less pronounced proliferative defect.<br /> (Copyright © 2018 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1879-0542
Volume :
198
Database :
MEDLINE
Journal :
Immunology letters
Publication Type :
Academic Journal
Accession number :
29601939
Full Text :
https://doi.org/10.1016/j.imlet.2018.03.014